Sharing Life Sciences Innovations

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

Dr. Paul Janssen Award for Biomedical Research

JANSSEN PHARMACEUTICA Company Restaurant Turnhoutseweg 30 2340 Beerse Belgium
Thu 06 Sep 2018
14:30

Johnson & Johnson has named James Allison, Ph.D., of University of Texas MD Anderson Cancer Center, winner of the 2018 Dr. Paul Janssen Award for Biomedical Research. Dr. Allison won for pioneerin…

Read more

Structural Dynamics in Cellular Communication (2nd edition)

Brussels, Belgium
Thu 20 Sep 2018 - Fri 21 Sep 2018
20 Sep 09:00 - 21 Sep 17:00

After a successful first edition in January 2015, with a great audience and speakers such as Nobel Prize winner Ada Yonath, we are honored to announce a second edition. This conference wi…

Read more

Business Developers Program for Life Sciences - Course

Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30 - 26 Sep 17:30

On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …

Read more

Biotechs and subsidies - a fraught relationship

Biotechs and subsidies - a fraught relationship

The ambition of any CEO heading a biotech start-up is to develop a new product and to reach patients quickly. However, drug development comes with long development timelines, making Biotech a capi…

Read more

Uncovering the secrets of inflammasomes

Uncovering the secrets of inflammasomes

Mohamed (Mo) Lamkanfi made the jump from academia to industry a mere eight months ago, to pursue a career with the Janssen Pharmaceutical Companies of Johnson & Johnson, as Head, Innate Immunity, …

Read more

The world's smallest diamonds

The world's smallest diamonds

Researchers at Hasselt University have just synthesised the world’s smallest diamonds. The gems, based on a 26-atom carbon core, will be useful in a whole range of industrial and medical applicati…

Read more

New beta cell antigens discovered in Type 1 diabetes

New beta cell antigens discovered in Type 1 diabetes

A study published just last week has unveiled several new antigens implicated in Type 1 diabetes. In an ongoing project, researchers are working to understand the immune system failures that cause…

Read more

Galapagos and MorphoSys to receive up to EUR 850mil in deal with Novartis

Galapagos and MorphoSys to receive up to EUR 850mil in deal with Novartis

Galapagos (Belgium) and MorphoSys (Germany) recently announced that they have entered into an exclusive global license agreement with Novartis. The Swiss big-pharma partner has acquired the rights…

Read more

Cycling for Science

Cycling for Science

Researchers from Ghent University have been able to map the effects of climate change thanks to images of the Tour of Flanders. By studying 36 years of footage of the popular cycling race, the res…

Read more

1 billion lifeforms recorded!

1 billion lifeforms recorded!

The Global Biodiversity Information Facility (GBIF) is an international network that provides access to a huge biodiversity database. Their total number of occurrence records just reached 1 billio…

Read more

Acquisitions of Biotech companies: a good or a bad thing?

Acquisitions of Biotech companies: a good or a bad thing?

When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…

Read more

How to build a “European Amgen”

How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech companies have managed to stay independent, grow,…

Read more

Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities

Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to support the…

Read more

Sanofi acquires Ablynx for €3.9 billion

Sanofi and Ablynx entered into a definitive agreement under which Sanofi will offer to acquire all of the outstanding ordinary shares, including shares represented by American Depositary Shares (A…

Read more

Nominations open for Dr. Paul Janssen Award

Have you ever heard from the Dr. Paul Janssen award? It's an acknowledgement for biomedical research almost as important as a Nobel Prize. A trophy sculpture, along with $200,000 cash, will go to …

Read more

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

Dr. Paul Janssen Award for Biomedical Research

JANSSEN PHARMACEUTICA Company Restaurant Turnhoutseweg 30 2340 Beerse Belgium
Thu 06 Sep 2018
14:30

Johnson & Johnson has named James Allison, Ph.D., of University of Texas MD Anderson Cancer Center, winner of the 2018 Dr. Paul Janssen Award for Biomedical Research. Dr. Allison won for pioneerin…

Read more

Structural Dynamics in Cellular Communication (2nd edition)

Brussels, Belgium
Thu 20 Sep 2018 - Fri 21 Sep 2018
20 Sep 09:00 - 21 Sep 17:00

After a successful first edition in January 2015, with a great audience and speakers such as Nobel Prize winner Ada Yonath, we are honored to announce a second edition. This conference wi…

Read more

Business Developers Program for Life Sciences - Course

Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30 - 26 Sep 17:30

On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Biowin Flanders.bio KU Leuven GSK V-Bio Ventures XpandInnovation Turnstone UGent Itera Life Science Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.